BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23073723)

  • 1. Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine.
    Nazari H; Yari F; Jariani M; Marzban A; Birgandy M
    Arch Gynecol Obstet; 2013 Mar; 287(3):469-72. PubMed ID: 23073723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in the treatment of premenstrual syndrome.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Erhan G
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):167-70. PubMed ID: 9228499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of four medications to treat severe premenstrual syndrome.
    Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA
    Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
    Gökben S; Ardıç UA; Serdaroğlu G
    Pediatr Neurol; 2012 Mar; 46(3):192-4. PubMed ID: 22353299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible serotonin syndrome associated with buspirone added to fluoxetine.
    Manos GH
    Ann Pharmacother; 2000; 34(7-8):871-4. PubMed ID: 10928399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
    Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
    Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases.
    Thomsen PH; Mikkelsen HU
    Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Landén M; Eriksson O; Sundblad C; Andersch B; Naessén T; Eriksson E
    Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
    Shehata NAA; Moety GAFA; El Wahed HAA; Fahim AS; Katta MA; Hussein GK
    Reprod Sci; 2020 Feb; 27(2):743-750. PubMed ID: 32046452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
    Michelson D; Bancroft J; Targum S; Kim Y; Tepner R
    Am J Psychiatry; 2000 Feb; 157(2):239-43. PubMed ID: 10671393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.
    Jin B; Alam M; Tierno A; Zhong H; Roy RR; Gerasimenko Y; Lu DC; Edgerton VR
    Neurotherapeutics; 2021 Apr; 18(2):1226-1243. PubMed ID: 33420588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine in the treatment of premenstrual syndrome.
    Stone AB; Pearlstein TB; Brown WA
    Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to sertraline treatment of severe premenstrual syndromes.
    Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
    J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
    Atmaca M; Kumru S; Tezcan E
    Hum Psychopharmacol; 2003 Apr; 18(3):191-5. PubMed ID: 12672170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.